Related Experiment Video
Updated: Jan 9, 2026

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
Bcl-XL mutations suppress cellular sensitivity to antimycin A
Michael K Manion1, Jason W O'Neill, Chris D Giedt
1Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Abstract:
Cells expressing high levels of the BCL-X(L) anti-apoptotic protein are preferentially killed by the mitochondrial inhibitor antimycin A (AA). Computational modeling predicts a binding site for AA in the extended hydrophobic groove on BCL-X(L), previously identified as an interface for dimerization to BAX and related proapoptotic proteins. Here, we identify BCL-X(L) hydrophobic groove mutants with normal cellular anti-apoptotic function but suppressed sensitivity to AA. The LD(50) of AA for cells expressing BCL-X(L) mutants directly correlates with the measured in vitro dissociation constants for AA binding. These results indicate that BCL-X(L) is a principal target mediating AA cytotoxicity.
Insights
The anti-apoptotic protein BCL-X(L) is a key target for the mitochondrial inhibitor antimycin A (AA). Mutating its hydrophobic groove reduces AA sensitivity, confirming BCL-X(L) mediates AA cytotoxicity.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The anti-apoptotic protein BCL-X(L) plays a critical role in cell survival.
- Mitochondrial inhibitors like antimycin A (AA) exhibit selective toxicity towards cells with high BCL-X(L) levels.
- Computational modeling suggested a binding site for AA within the BCL-X(L) hydrophobic groove.
Purpose of the Study:
- To investigate the role of the BCL-X(L) hydrophobic groove in mediating sensitivity to antimycin A.
- To identify specific mutations in BCL-X(L) that alter its interaction with antimycin A.
- To confirm BCL-X(L) as a principal target for antimycin A-induced cytotoxicity.
Main Methods:
- Site-directed mutagenesis of the BCL-X(L) hydrophobic groove.
- Cellular assays to assess anti-apoptotic function and antimycin A sensitivity.
- In vitro binding assays to measure antimycin A dissociation constants.
Main Results:
- BCL-X(L) mutants with alterations in the hydrophobic groove retained normal anti-apoptotic function.
- These BCL-X(L) mutants exhibited significantly reduced sensitivity to antimycin A.
- The reduction in antimycin A sensitivity directly correlated with decreased in vitro binding affinity.
Conclusions:
- The hydrophobic groove of BCL-X(L) is a critical determinant of sensitivity to antimycin A.
- BCL-X(L) is identified as a principal molecular target responsible for antimycin A cytotoxicity.
- These findings provide insights into the mechanism of action of antimycin A and the regulation of apoptosis.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

